| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.071 | 0.05 |
| mRNA | Oxaliplatin | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.05 |
| mRNA | JNJ-26854165 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.05 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.078 | 0.05 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.074 | 0.05 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.05 |
| mRNA | PI-103 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |